Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
FDA mandates label updates on CAR-T cancer therapies
Reuters
Thu, 04/18/24 - 10:34 pm
CAR-T
FDA
warning
cancer
Gilead Sciences
Bristol Myers Squibb
2seventybio
Brazil’s plan for low-cost CAR-Ts
Stat
Wed, 03/27/24 - 10:49 am
Brazil
CAR-T
Becoming ‘biologic-like’: CAR-T makers on quest to scale drugs’ production
Medical Marketing and Media
Mon, 03/18/24 - 05:13 pm
CAR-T
FDA
drug development
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
JNJ
Legend Biotech
CAR-T
FDA
Carvykti
Abecma
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Bristol Myers Squibb
CAR-T
CLL
Breyanzi
FDA
JNJ
Carvykti
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year
Fierce Biotech
Fri, 02/23/24 - 10:32 am
Galapagos
layoffs
lupus
CAR-T
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
Stat
Wed, 02/21/24 - 10:47 pm
CAR-T
New England Journal of Medicine
autoimmune disease
FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma
Medical Marketing and Media
Fri, 02/16/24 - 11:42 am
CAR-T
FDA
Peter Marks
CBER
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Bristol Myers Squibb
Abecma
FRDA
CAR-T
JNJ
Carvykti
Gilead’s Kite Gets FDA Approval for Faster CAR T Therapy Manufacturing
BioSpace
Wed, 01/31/24 - 11:58 am
Gilead Sciences
Kite Pharma
FDA
drug manufacturing
Yescarta
CAR-T
FDA Reveals More Details on 22 CAR-T Secondary Cancer Cases
BioSpace
Thu, 01/25/24 - 11:03 am
CAR-T
cancer
FDA
Gilead's Tecartus gets revised safety demand amid FDA's push for CAR-T boxed warnings
Fierce Pharma
Wed, 01/24/24 - 10:46 am
Gilead Sciences
Tecartus
CAR-T
FDA
FDA requires 'boxed warning' for CAR-T cancer therapies
Reuters
Mon, 01/22/24 - 10:10 pm
CAR-T
FDA
warnings
Gilead Sciences
JNJ
Novartis
CAR-T hype faces infrastructure reality check
Fierce Pharma
Tue, 01/16/24 - 09:22 am
CAR-T
cell therapy
gene therapy
Gilead Sciences
JNJ
FDA’s CAR T Probe ‘Not a Big Deal’ for Oncology-Focused Biotechs: Triumvira President
BioSpace
Wed, 01/10/24 - 06:25 pm
oncology
CAR-T
regulatory
FDA
Allogene to shift strategy in bid to reposition CAR-T
BioPharma Dive
Fri, 01/5/24 - 10:03 am
Allogene Therapeutics
cell therapy
cancer
CAR-T
Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review
BioSpace
Wed, 12/20/23 - 09:36 am
CAR-T
FDA
cancer
Oncologists Defend CAR-T After FDA Advisory
BioSpace
Mon, 12/18/23 - 10:11 am
oncologists
CAR-T
cancer
FDA
FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates
BioSpace
Fri, 12/15/23 - 11:14 am
CARsgen
FDA
cell therapy
CAR-T
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »